The Asia Pacific heart valve device market will experience robust growth through 2029, driven by economic expansion, an aging population, and the adoption of THV devices. However, market growth will be hindered to some extent due to the COVID-19 pandemic.

This Medtech 360 Report provides high-level market metrics for heart valve devices in Asia Pacific markets, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.

Table of contents

  • Heart Valve Devices - Market Insights - Asia Pacific (Supplemental)
    • Abstract
    • Key Report Updates
      • COVID-19 Forecast Factors
        • Heart Valve Device Market
          • Market Definitions
            • Geographies Covered, Asia Pacific
            • Heart Valve Device Procedures and Products Covered, Asia Pacific
          • Market Forecast Data
            • Heart Valve Device Market, by Product Type, Asia Pacific (USD), 2019–2029
            • Heart Valve Device Procedures, by Product Type, Asia Pacific, 2019–2029
            • Heart Valve Device Procedures, by Country, Asia Pacific, 2019–2029
            • Heart Valve Device Market, by Product Type, Asia Pacific (USD), 2019–2029
            • Heart Valve Device Market, by Technique, Asia Pacific (USD), 2019–2029
            • Heart Valve Device Market, by Country, Asia Pacific (USD), 2019–2029
        • Heart Valve Replacement Device Market
          • Market Definitions
            • Market Forecast Data
              • Heart Valve Replacement Device Market, by Product Type, Asia Pacific (USD), 2019–2029
              • Heart Valve Replacement Procedures, by Technique, Asia Pacific, 2019–2029
              • Heart Valve Replacement Procedures, by Country, Asia Pacific, 2019–2029
              • Heart Valve Replacement Device Market, by Technique, Asia Pacific (USD), 2019–2029
              • Heart Valve Replacement Device Market, by Country, Asia Pacific (USD), 2019–2029
              • Surgical Heart Valve Replacement Procedures, by Product Type, Asia Pacific, 2019–2029
              • Surgical Heart Valve Replacement Procedures, by Country, Asia Pacific, 2019–2029
              • Surgical Heart Valve Replacement Device Market, by Product Type, Asia Pacific (USD), 2019–2029
              • Surgical Heart Valve Replacement Device Market, by Country, Asia Pacific (USD), 2019–2029
              • Tissue Heart Valve Procedures, by Country, Asia Pacific, 2019–2029
              • Tissue Heart Valve Market, by Country, Asia Pacific (USD), 2019–2029
              • Tissue Heart Valve Market Growth, by Country, Asia Pacific, 2020–2029
              • Mechanical Heart Valve Procedures, by Country, Asia Pacific, 2019–2029
              • Mechanical Heart Valve Market, by Country, Asia Pacific (USD), 2019–2029
              • Mechanical Heart Valve Market Growth, by Country, Asia Pacific, 2020–2029
              • Transcatheter Heart Valve Replacement Device Market, Asia Pacific (USD), 2019–2029
          • Heart Valve Repair Device Market
            • Market Definitions
              • Market Forecast Data
                • Heart Valve Repair Device Market, by Technique, Asia Pacific (USD), 2019–2029
                • Heart Valve Repair Procedures, by Technique, Asia Pacific, 2019–2029
                • Heart Valve Repair Procedures, by Country, Asia Pacific, 2019–2029
                • Heart Valve Repair Device Market, by Technique, Asia Pacific (USD), 2019–2029
                • Heart Valve Repair Device Market, by Country, Asia Pacific (USD), 2019–2029
                • Annuloplasty Device Procedures, by Country, Asia Pacific, 2019–2029
                • Annuloplasty Device Market, by Country, Asia Pacific (USD), 2019–2029
                • Annuloplasty Device Market Growth, by Country, Asia Pacific, 2020–2029
                • TMVR Device Market, Asia Pacific (USD), 2019–2029
            • Appendix
              • Abbreviations

            Author(s): Suraj Nair, Masters in Bioprocess Technology; Vijay Mohan Motwani

            Suraj Nair is a Research Associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in the Electrophysiology Mapping and Ablation Devices Market. Suraj holds a Master’s degree in Bioprocess Technology from the Institute of Chemical Technology, Mumbai and has a prior experience of working in the biopharmaceutical industry for two years and in the market research industry for medical devices for a year. 

            Vijay Motwani is a member of the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in the dialysis access treatment device and transcatheter embolization and occlusion device markets. Vijay holds a Bachelor's degree in Pharmaceutical Sciences from Bharati Vidyapeeth Deemed University and a Master’s degree in Pharmaceutical Quality Assurance from the Manipal Academy of Higher Education, Manipal.